Tower Research Capital (TRC)’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-645
| Closed | -$2.65K | – | 5890 |
|
|
2024
Q3 | $2.65K | Buy |
+645
| New | +$2.65K | ﹤0.01% | 4956 |
|
|
2024
Q2 | – | Sell |
-7,145
| Closed | -$23.6K | – | 5890 |
|
|
2024
Q1 | $23.6K | Buy |
+7,145
| New | +$23.6K | ﹤0.01% | 2852 |
|
|
2023
Q1 | – | Sell |
-15,129
| Closed | -$11K | – | 6110 |
|
|
2022
Q4 | $11K | Buy |
15,129
+2,562
| +20% | +$1.86K | ﹤0.01% | 3846 |
|
|
2022
Q3 | $11K | Buy |
12,567
+233
| +2% | +$204 | ﹤0.01% | 4453 |
|
|
2022
Q2 | $14K | Buy |
12,334
+12,273
| +20,120% | +$13.9K | ﹤0.01% | 4151 |
|
|
2022
Q1 | $0 | Sell |
61
-33,620
| -100% | – | ﹤0.01% | 6385 |
|
|
2021
Q4 | $54K | Buy |
33,681
+33,052
| +5,255% | +$53K | ﹤0.01% | 2711 |
|
|
2021
Q3 | $2K | Buy |
+629
| New | +$2K | ﹤0.01% | 5274 |
|
|
2019
Q4 | – | Sell |
-1,738
| Closed | -$5K | – | 4072 |
|
|
2019
Q3 | $5K | Buy |
1,738
+945
| +119% | +$2.72K | ﹤0.01% | 3314 |
|
|
2019
Q2 | $2K | Buy |
+793
| New | +$2K | ﹤0.01% | 3287 |
|